BRPI0815134A2 - Processo para a preparação de olmesartana medoxomila - Google Patents

Processo para a preparação de olmesartana medoxomila

Info

Publication number
BRPI0815134A2
BRPI0815134A2 BRPI0815134-2A2A BRPI0815134A BRPI0815134A2 BR PI0815134 A2 BRPI0815134 A2 BR PI0815134A2 BR PI0815134 A BRPI0815134 A BR PI0815134A BR PI0815134 A2 BRPI0815134 A2 BR PI0815134A2
Authority
BR
Brazil
Prior art keywords
olmesartana
medoxomila
preparing
relates
olmesartan medoxomil
Prior art date
Application number
BRPI0815134-2A2A
Other languages
English (en)
Portuguese (pt)
Inventor
Renata Toplak Casar
Original Assignee
Lek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07114000A external-priority patent/EP2022790A1/en
Priority claimed from EP07114004A external-priority patent/EP2036904A1/en
Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals
Publication of BRPI0815134A2 publication Critical patent/BRPI0815134A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0815134-2A2A 2007-08-08 2008-08-07 Processo para a preparação de olmesartana medoxomila BRPI0815134A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07114000A EP2022790A1 (en) 2007-08-08 2007-08-08 A process for the preparation or purification of olmesartan medoxomil
EP07114004A EP2036904A1 (en) 2007-08-08 2007-08-08 A process for the preparation of olmesartan medoxomil
PCT/EP2008/060400 WO2009019304A1 (en) 2007-08-08 2008-08-07 A process for the preparation of olmesartan medoxomil

Publications (1)

Publication Number Publication Date
BRPI0815134A2 true BRPI0815134A2 (pt) 2015-02-03

Family

ID=39789494

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0815134-2A2A BRPI0815134A2 (pt) 2007-08-08 2008-08-07 Processo para a preparação de olmesartana medoxomila
BRPI0815111-3A2A BRPI0815111A2 (pt) 2007-08-08 2008-08-07 Processo para a preparação ou purificação de olmesartan medoxomil, sais de olmesartan medoxomil e seus usos e composições farmacêuticas

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0815111-3A2A BRPI0815111A2 (pt) 2007-08-08 2008-08-07 Processo para a preparação ou purificação de olmesartan medoxomil, sais de olmesartan medoxomil e seus usos e composições farmacêuticas

Country Status (9)

Country Link
US (2) US20110224271A1 (enExample)
EP (2) EP2173741B1 (enExample)
JP (2) JP2010535743A (enExample)
CN (2) CN101778842B (enExample)
AT (1) ATE528305T1 (enExample)
BR (2) BRPI0815134A2 (enExample)
CA (2) CA2707334C (enExample)
SI (1) SI2176253T1 (enExample)
WO (2) WO2009019304A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE528305T1 (de) * 2007-08-08 2011-10-15 Lek Pharmaceuticals Verfahren zur herstellung oder reinigung von olmesartan-medoxomil oder von olmesartan- medoxomil-hydrohalid-salz
CA2727220C (en) 2008-06-09 2015-07-28 Daiichi Sankyo Company, Limited Method for producing a 1-biphenylmethylimidazole compound
US8933241B2 (en) 2009-04-28 2015-01-13 Daiichi Sankyo Company, Limited Method for producing olmesartan medoxomil
ES2753874T3 (es) * 2009-04-28 2020-04-14 Daiichi Sankyo Co Ltd Cristales de solvato novedosos
WO2011007368A2 (en) * 2009-07-14 2011-01-20 Cadila Healthcare Limited An improved process for preparation of olmesartan
CA2769704A1 (en) * 2009-07-31 2011-02-03 Ranbaxy Laboratories Limited Polymorphic form of olmesartan medoxomil
WO2011021224A2 (en) * 2009-08-19 2011-02-24 Msn Laboratories Limited Process for (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl4-(1-hydroxy-1-methylethyl)-2-propyl-1-[4-[2-tetrazol-5-yl)phenyl]phenyl]methylimidazole-5-carboxylate
CZ303188B6 (cs) * 2010-10-29 2012-05-16 Zentiva, K.S. Zpusob výroby olmesartanu medoxomilu
KR101275092B1 (ko) * 2011-05-19 2013-06-17 한미정밀화학주식회사 아질사르탄의 개선된 제조방법
CN102351849B (zh) * 2011-10-26 2013-10-02 齐鲁天和惠世制药有限公司 一种奥美沙坦酯的制备方法
CN103304550B (zh) * 2012-03-16 2016-01-27 湖南欧亚生物有限公司 一种奥美沙坦酯的制备方法
CN103319461A (zh) * 2013-07-02 2013-09-25 临海天宇药业有限公司 奥美沙坦酯中间体的制备方法以及奥美沙坦酯的合成方法
CN103435602A (zh) * 2013-07-31 2013-12-11 山东省医学科学院药物研究所 一种奥美沙坦酯的制备方法
CN104262332A (zh) * 2014-09-16 2015-01-07 上海信谊百路达药业有限公司 一种奥美沙坦酯的制备方法
CN104447715B (zh) * 2014-11-28 2017-06-20 山东新华制药股份有限公司 奥美沙坦酯的制备方法
CN104817546B (zh) * 2015-05-20 2020-02-07 浙江华海药业股份有限公司 一种奥美沙坦酯母液回收的方法
CN107311990B (zh) * 2017-07-25 2021-09-03 浙江华海致诚药业有限公司 一种奥美沙坦酯的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
ES2155827T3 (es) * 1992-06-02 2001-06-01 Sankyo Co 4-carboxiimidazoles como antagonistas de la angiotensina ii y su uso terapeutico.
JP2001226372A (ja) * 1999-12-06 2001-08-21 Sumika Fine Chemicals Co Ltd ロサルタンの結晶性または結晶化された酸付加塩およびロサルタンの精製方法
ITMI20032338A1 (it) * 2003-11-28 2005-05-29 Dinamite Dipharma S P A In Forma A Bbreviata Diph Composti feniltetrazolici.
EP1706401A1 (en) 2004-09-02 2006-10-04 Teva Pharmaceutical Industries Ltd. Preparation of olmesartan medoxomil
CA2575177A1 (en) * 2004-09-02 2006-03-16 Teva Pharmaceutical Industries Ltd. Purification of olmesartan medoxomil
GB2419592A (en) * 2004-10-26 2006-05-03 Cipla Ltd Process for the preparation of irbesartan hydrochloride
US20060281800A1 (en) 2005-04-12 2006-12-14 Glenmark Pharmaceuticals Limited Polymorphic form of olmesartan and process for its preparation
EP1816131A1 (en) 2006-02-06 2007-08-08 KRKA, tovarna zdravil, d.d., Novo mesto Process for the preparation of olmesartan medoxomil
WO2007017135A2 (en) * 2005-07-29 2007-02-15 Krka Process for the preparation of olmesartan medoxomil
WO2007052301A2 (en) 2005-08-31 2007-05-10 Alembic Limited Process for the preparation of irbesartan
EP1801111B1 (en) 2005-12-20 2014-07-16 LEK Pharmaceuticals d.d. Novel polymorph forms of olmesartan medoxomil
WO2007115990A1 (en) 2006-04-07 2007-10-18 Lek Pharmaceuticals D.D. Process for the preparation of pure irbesartan
US8048904B2 (en) 2006-06-19 2011-11-01 Matrix Laboratories Ltd. Process for the preparation of olmesartan medoxomil
JP5269798B2 (ja) * 2006-10-09 2013-08-21 シプラ・リミテッド トリチルオルメサルタンメドキソミルおよびオルメサルタンメドキソミルの製造方法
ATE528305T1 (de) * 2007-08-08 2011-10-15 Lek Pharmaceuticals Verfahren zur herstellung oder reinigung von olmesartan-medoxomil oder von olmesartan- medoxomil-hydrohalid-salz

Also Published As

Publication number Publication date
WO2009019303A3 (en) 2009-04-02
CN101778843A (zh) 2010-07-14
WO2009019303A2 (en) 2009-02-12
WO2009019304A1 (en) 2009-02-12
US8592474B2 (en) 2013-11-26
CA2707365A1 (en) 2009-02-12
CA2707334A1 (en) 2009-02-12
JP2010535743A (ja) 2010-11-25
SI2176253T1 (sl) 2012-02-29
BRPI0815111A2 (pt) 2015-01-27
EP2176253B1 (en) 2011-10-12
US20110263666A1 (en) 2011-10-27
EP2173741B1 (en) 2013-10-02
CA2707334C (en) 2015-11-24
US20110224271A1 (en) 2011-09-15
JP5685082B2 (ja) 2015-03-18
CN101778842A (zh) 2010-07-14
EP2173741A1 (en) 2010-04-14
CN101778842B (zh) 2014-10-29
ATE528305T1 (de) 2011-10-15
JP2010535742A (ja) 2010-11-25
EP2176253A2 (en) 2010-04-21

Similar Documents

Publication Publication Date Title
BRPI0815134A2 (pt) Processo para a preparação de olmesartana medoxomila
EA201200506A1 (ru) СПОСОБ ПОЛУЧЕНИЯ КРИСТАЛЛИЧЕСКОЙ ФОРМЫ 1-ХЛОР-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)-2-(4-((S)-ТЕТРАГИДРОФУРАН-3-ИЛОКСИ)БЕНЗИЛ)БЕНЗОЛА
CY1119474T1 (el) Κρυσταλλικες μορφες 5-χλωρο-ν2-(2-ισοπροποξυ-5-μεθυλ-4-πιπεριδιν-4-υλ-φαινυλ)-ν4[2-(προπανο-2-σουλφονυλ)-φαινυλ]-πυριμιδιν-2,4-διαμινης
UY32062A (es) Inhibidores de beta-secretasa
UY32174A (es) Nuevos heterociclos sustituidos, composiciones farmaceuticas conteniendolos, procedimientos de preparacion y aplicaciones
GT201200158A (es) Procedimiento para la preparación de {4,6-diamino-2-[1-(2-fluorobencil)-1h-pirazolo[3,4-b]piridin-3-il]pirimidin-5-il}metilcarbamato de metilo y su purificación para su uso como principio activo farmacéutico
GT201200164A (es) "nuevos compuestos de espiropiperidina"
EA201200551A1 (ru) Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения
EA200970247A1 (ru) Способ получения оптического активного n-защищенного 3-аминопирролидина или оптически активного n-защищенного 3-аминопиперидина и соответствующих кетонов путем оптического разделения рацемических смесей аминов с использованием бактериальной омега-трансаминазы
NO20084850L (no) MGLUR5 modulatorer I
EA201190235A1 (ru) Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750
EA201171151A1 (ru) Кристаллические трипептидные ингибиторы эпоксикетон-протеазы
DE602006012665D1 (de) Kristalline formen von 1-chloro-4-(beta-d-glucopyranos-1-yl)-2-ä4-((r)-tetrahydrofuran-3-yloxy)-benzylü-benzol, zubereitungsverfahren dafür und dessen verwendung zur arzneimittelherstellung
EA200970581A1 (ru) Кристаллическое твёрдое основание разагилина
GT201400111A (es) Triazolopiridinas sustituidas
WO2011057262A3 (en) Treatment of infections with tp receptor antagonists
EA201290032A1 (ru) Синтез и применение вилдаглиптина для получения лекарственных форм
EA201270280A1 (ru) Соединения пиримидина в качестве ингибиторов при лечении туберкулеза
EA201200616A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
UY32052A (es) 5-aminopirazoles sustituidos y uso de los mismos
BR112012016201A2 (pt) ''composto, processo para a preparação de um composto, composição farmacêutica e uso de um composto''
BRPI0813427A2 (pt) Composto, uso do mesmo, método para tratar a infecção bacteriana em um animal de sangue quente, composição farmacêutica, e, processo para a preparação de um composto.
MX2013009531A (es) Proceso para preparar productos que comprenden activos estabilizados y composiciones que los comprenden.
CL2011001829A1 (es) 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo.
MA32945B1 (fr) Tétrahydropyrane spiro pyrrolidinone et pipéridinone substituées, leur préparation et leur utilisation thérapeutique

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]